πŸ‡ΊπŸ‡Έ FDA
Patent

US 12281078

Quinoline cGAS antagonist compounds

granted A61PA61P25/00A61P29/00

Quick answer

US patent 12281078 (Quinoline cGAS antagonist compounds) held by The Board of Regents of the University of Texas System expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P25/00, A61P29/00, A61P9/00